TF and liver cancer: Considering the subgroup of patients with primary liver cancer for whom data on TF mRNA expression analysis were available (n = 91), subjects with high TF mRNA levels in cancer tissue had marginally higher FVIIa-AT plasma levels than those in subjects with low TF mRNA levels (99.8 pM [95% CI, 88.4-112.6] vs 84.5 pM [95% CI, 75.2-94.9 pM]; P = .050).